Updates

Akums Drugs and Pharmaceuticals Limited has announced it has sent letters to shareholders who have not registered their email IDs. These letters provide a web-link to the company's Integrated Annual Report for the Financial Year 2025-26. This action is taken pursuant to Regulation 36(1)(b) of SEBI Listing Regulations, ensuring compliance with disclosure requirements. For investors, this update highlights the company's commitment to transparent communication and facilitating access to important financial information for all shareholders. No new financial figures or strategic decisions were announced in this procedural update.